IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: A phase I dose-escalation study

被引:0
作者
Liu, Rujiao
Hu, Xichun
Song, Zhengbo
Zhang, Jian
Jin, Jianan
Gao, Shuiping
Sun, Yuping
Zhang, Yan
Gao, Shegan
Jia, Ruinuo
Jing, Deqiang
Xu, Yu
Wang, Zhenjiu
Lu, Qiying
Tian, Wenzhi
Cheng, Xiangdong
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Shandong Prov Inst Canc Prevent & Treatment, Jinan, Peoples R China
[4] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[5] ImmuneOnco Biopharmaceut Shanghai Inc, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14506
引用
收藏
页数:1
相关论文
empty
未找到相关数据